High-dose methotrexate for elderly patients with primary CNS lymphoma (Q37256189)

19 August 2017

High-dose methotrexate for elderly patients with primary CNS lymphoma (English)

1 reference

19 August 2017

0 references

1 reference

8

Rebecca A Betensky

1 reference

19 August 2017

Jay-Jiguang Zhu

1

1 reference

19 August 2017

Elizabeth R Gerstner

2

1 reference

19 August 2017

David A Engler

3

1 reference

19 August 2017

Maciej M Mrugala

4

1 reference

19 August 2017

Whitney Nugent

5

1 reference

19 August 2017

Kristin Nierenberg

6

1 reference

19 August 2017

Fred H Hochberg

7

1 reference

19 August 2017

Tracy T Batchelor

9

1 reference

19 August 2017

29 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

11

1 reference

19 August 2017

2

1 reference

19 August 2017

211-215

1 reference

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Gene expression and angiotropism in primary CNS lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Primary nervous-system lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

High-dose methotrexate for primary CNS lymphoma in the elderly

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Cognitive functions in survivors of primary central nervous system lymphoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

High-dose methotrexate for intraocular lymphoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

A multicenter study of treatment of primary CNS lymphoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718993

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757775

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757775

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term survival in primary CNS lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757775

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1215/15228517-2008-067

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

18757775

1 reference